Oddo BHF - Knaus Tabbert (KTA) Knaus Tabbert AG : 3eme profit warning en 2024 et arrêt de la production sur 2 sites jusqu’à la fin de l’année

Report

Oddo BHF

Christophe Chaput ...

Hela Zarrouk

Knaus Tabbert AG : 3eme profit warning en 2024 et arrêt de la production sur 2 sites jusqu’à la fin de l’année

>Arrêt de la production sur les 2 principaux sites et un CA 2024 qui sera significativement inférieur à la guidance 2024 de 1.3 Md€ - Knaus Tabbert a publié un communiqué en cours de séance hier, indiquant qu’à partir du 18 novembre et jusqu’à la fin de l’année, le groupe a décidé d’arrêter la production sur les sites de Jandelsbrunn (Allemagne) et Nagyoroszi (Hongrie). Ces 2 sites représentent environ 75% des effectifs du groupe. En conséquence, le CA 2024 est attend...

14/11/2024 1 FR

Underlying

Knaus Tabbert

See profile

DE000A2YN504 Germany

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Christophe Chaput

Hela Zarrouk

Other Reports on these Companies

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - Date1

We initiate coverage of Heijmans, a contractor focused on the Dutch market, with an Outperform rating and a TP of € 36.5 (DCF based). The Dutch residential market is finally recovering, and we believe Heijmans is well-positioned to benefit due to its land bank and property development arm, driving up revenues while EBITDA margins are expected to exceed 8.5% in the Living unit. Heijmans is also benefitting from strong demand from the infrastructure and energy markets, allowing for soli...

7h / 1m 7h / 1m 1 FR

Oddo BHF

ODDO BHF Small & MIDCAP MORNING NEWS - 11/14/2024

7h / 6m 7h / 6m 1 EN

Oddo BHF

Knaus Tabbert AG : Third profit warning in 2024, production halted at two sites until year-end

>Production stopped at the two main sites, 2024 revenues set to be well below 2024 guidance, set at € 1.3bn - Knaus Tabbert published a press release during yesterday's trading session, where it said it decided to cease production at its Jandelsbrunn (Germany) and Nagyoroszi (Hungary) sites from 18 November until the end of the year. These two sites account for around 75% of the group's workforce. As a result, 2024 revenues are expected to be significantly lower than ...

9h / 1m 9h / 1m 1 EN

Accelleron : Straight and smooth sailing with a compounder profile

Swiss-based Accelleron was formed from the spin-off of ABB’s highly profitable turbocharger division in 2022. We view the share as a promising investment on 1/ market leadership in an attractive niche, 2/ about ~40% ROCE, 3/ conversion of ~80% of EBITDA into cash, leading to fast deleveraging, and a solid base for shareholder remuneration (75% pay out), and 4/ strong long-term visibility linked to a ~75% service share, the bulk of which is recurring. Despite an already strong sto...

50m 50m 1 EN

Oliver Metzger ... (+2)

Oliver Metzger
Stephan Wulf

Dermapharm Holding SE : All divisions contribute to better-than-expected 9M figures

>A strong set of 9M figures beats expectations - 9M sales of € 890m (+3%) came in 1% above our (€ 886m) and 2% above the consensus compiled by the company of € 871m. Adjusted EBITDA of € 240m (-1%) is 5% above our estimates of € 229m and 8% above consensus of € 223m. The slightly lower profitability vs 9M 2023 (adjusted EBITDA margin of 27% vs 28%) still reflects the absence of sales from the extremely attractive contract with BioNTech, which still supported Q1 2023....

6h / 59m 6h / 59m 1 EN

Thijs Berkelder ... (+2)

Thijs Berkelder
Usama Tariq

ODDO BHF Small & MIDCAP MORNING NEWS - Date1

7h / 1m 7h / 1m 1 FR

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Knaus Tabbert AG : 3eme profit warning en 2024 et arrêt de la production sur 2 sites jusqu’à la fin de l’année

ODDO BHF Small & MIDCAP MORNING NEWS - Date1

ODDO BHF Small & MIDCAP MORNING NEWS - 11/14/2024

Knaus Tabbert AG : Third profit warning in 2024, production halted at two sites until year-end

Accelleron : Straight and smooth sailing with a compounder profile

Dermapharm Holding SE : All divisions contribute to better-than-expected 9M figures

ODDO BHF Small & MIDCAP MORNING NEWS - Date1

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe